Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds

Details for Australian Patent Application No. 2008256928 (hide)

Owner Allergan, Inc.

Inventors Sinha, Santosh C.; Chow, Ken; Heidelbaugh, Todd M.; Garst, Michael E.; Bhat, Smita S.

Agent Davies Collison Cave

Pub. Number AU-A-2008256928

PCT Pub. Number WO2008/147788

Priority 60/939,775 23.05.07 US

Filing date 21 May 2008

Wipo publication date 4 December 2008

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4725 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/147788 Priority application(s): WO2008/147788

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008256933-Improving grinding in a alumina extraction process

2008256926-((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists